Irving

Irving Life Sciences is a pre-clinical stage biotechnology company focused on the discovery and development of transformative therapeutics in the field of oncology. As a portfolio company of TCG Labs Soleil, the firm leverages a specialized research and development model to advance novel drug candidates toward clinical validation. The company's primary business involves identifying high-value targets and developing therapeutic programs that can be strategically integrated into pharmaceutical pipelines. Irving Life Sciences operates within a collaborative ecosystem designed to de-risk early-stage assets before transitioning them to partners for late-stage development.